Market cap
₹481 Cr
Revenue (TTM)
₹42 Cr
P/E Ratio
47.1
P/B Ratio
--
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | 57.77 | -- | -- |
| EBIT | -- | -- | 179.31 | -- | -- |
| Net Profit | -- | -- | 188.07 | -- | -- |
| EPS | -- | -- | 181.30 | -- | -- |
| Book Value | -- | -- | 97.14 | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-25 | Mar-24 | Mar-23 |
| EBIT-Margin
| -- | -- | 22.21 | 12.55 | 7.36 |
| Net Margin
| -- | -- | 12.21 | 6.62 | 3.83 |
| Return on equity
| -- | -- | 34.24 | 19.71 | 10.62 |
| Return on Capital
| -- | -- | 20.17 | 12.02 | 6.88 |
| Return on Assets
| -- | -- | 8.37 | 4.67 | 2.55 |
| Debt to Equity (x)
| -- | -- | 1.92 | 2.44 | 2.18 |
Profitability
ROCE
20.17
Higher than Peers by 6.73
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
HRS Aluglaze
|
20.17
|
12.02
|
6.88
|
--
|
--
|
|
Peer Median
|
13.43
|
14.31
|
10.82
|
10.30
|
--
|
ROE
34.24
Higher than Peers by 24.52
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
HRS Aluglaze
|
34.24
|
19.71
|
10.62
|
--
|
--
|
|
Peer Median
|
9.72
|
9.24
|
12.97
|
3.29
|
--
|
ROA
8.37
Higher than Peers by 1.52
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
HRS Aluglaze
|
8.37
|
4.67
|
2.55
|
--
|
--
|
|
Peer Median
|
6.85
|
5.92
|
5.64
|
4.38
|
--
|
EBIT Margin
22.21
Higher than Peers by 13.22
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
HRS Aluglaze
|
22.21
|
12.55
|
7.36
|
--
|
--
|
|
Peer Median
|
8.99
|
8.42
|
5.24
|
8.92
|
--
|
Net Margin
12.21
Higher than Peers by 7.38
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
HRS Aluglaze
|
12.21
|
6.62
|
3.83
|
--
|
--
|
|
Peer Median
|
4.83
|
3.76
|
6.02
|
2.96
|
--
|
Cash Profit Margin
15.43
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
HRS Aluglaze
|
15.43
|
7.39
|
4.24
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
57.77
Higher than Peers by 52.87
Year on year growth in net sales
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
HRS Aluglaze
|
57.77
|
18.35
|
--
|
--
|
--
|
|
Peer Median
|
4.90
|
4.26
|
24.67
|
55.46
|
--
|
EBIT Growth
179.31
Higher than Peers by 157.81
Year on year growth in operating profit (EBIT)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
HRS Aluglaze
|
179.31
|
101.78
|
--
|
--
|
--
|
|
Peer Median
|
21.50
|
31.27
|
6.09
|
167.28
|
--
|
Net Profit Growth
188.07
Higher than Peers by 161.96
Year on year growth in profit after tax
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
HRS Aluglaze
|
188.07
|
105.79
|
--
|
--
|
--
|
|
Peer Median
|
26.11
|
19.14
|
8.68
|
216.60
|
--
|
EPS Growth
181.31
Higher than Peers by 147.00
Year on year growth in earnings per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
HRS Aluglaze
|
181.31
|
105.79
|
--
|
--
|
--
|
|
Peer Median
|
34.31
|
46.08
|
22.22
|
215.89
|
--
|
Book Value Growth
101.88
--
Year on year growth in book value per share
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
HRS Aluglaze
|
101.88
|
21.86
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
1.92
Higher than Peers by 1.60
Total debt / Net worth
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
HRS Aluglaze
|
1.92
|
2.44
|
2.18
|
--
|
--
|
|
Peer Median
|
0.32
|
0.33
|
0.22
|
0.19
|
--
|
Short term debt to equity ratio
0.55
--
(Short term borrowings / Net worth)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
HRS Aluglaze
|
0.55
|
0.49
|
0.04
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
0.92
Lower than Peers by 0.58
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
HRS Aluglaze
|
0.92
|
0.84
|
0.88
|
--
|
--
|
|
Peer Median
|
1.50
|
1.34
|
1.66
|
1.32
|
--
|
Quick Ratio
0.47
Lower than Peers by 0.95
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
HRS Aluglaze
|
0.47
|
0.46
|
0.54
|
--
|
--
|
|
Peer Median
|
1.42
|
1.26
|
0.91
|
0.80
|
--
|
Interest Coverage
3.74
Lower than Peers by 1.02
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
HRS Aluglaze
|
3.74
|
2.96
|
3.08
|
--
|
--
|
|
Peer Median
|
4.76
|
7.75
|
3.48
|
3.05
|
--
|
Operating Efficiency
Debtors to sales
31.33
Higher than Peers by 22.34
Debtors outstanding / Net Sales * 100
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
HRS Aluglaze
|
31.33
|
16.87
|
13.10
|
--
|
--
|
|
Peer Median
|
8.99
|
7.90
|
7.08
|
6.91
|
--
|
Asset Turnover
0.68
Lower than Peers by 0.71
Sales / Average Total Assets
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
HRS Aluglaze
|
0.68
|
0.70
|
0.66
|
--
|
--
|
|
Peer Median
|
1.40
|
1.64
|
1.37
|
1.01
|
--
|
Receivable days
76.69
--
Average Debtors / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
HRS Aluglaze
|
76.69
|
50.98
|
47.80
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
91.57
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
HRS Aluglaze
|
91.57
|
59.85
|
51.29
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
175.57
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
HRS Aluglaze
|
175.57
|
145.60
|
109.48
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
-7.31
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
HRS Aluglaze
|
-7.31
|
-34.77
|
-10.39
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
HRS Aluglaze
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
25.09
|
25.61
|
15.74
|
13.44
|
--
|
Price / Book Value
--
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
HRS Aluglaze
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
2.45
|
2.66
|
1.23
|
1.04
|
--
|
EV/EBITDA
4.21
Lower than Peers by 15.50
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
HRS Aluglaze
|
4.21
|
8.09
|
12.92
|
--
|
--
|
|
Peer Median
|
19.71
|
20.87
|
9.18
|
8.09
|
--
|
Market Cap
--
--
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
|---|---|---|---|---|---|
|
HRS Aluglaze
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
497
|
469
|
320
|
280
|
--
|